ATE463572T1 - Rekombinanter faktor viii mit erhöhter spezifischer aktivität - Google Patents

Rekombinanter faktor viii mit erhöhter spezifischer aktivität

Info

Publication number
ATE463572T1
ATE463572T1 AT04812686T AT04812686T ATE463572T1 AT E463572 T1 ATE463572 T1 AT E463572T1 AT 04812686 T AT04812686 T AT 04812686T AT 04812686 T AT04812686 T AT 04812686T AT E463572 T1 ATE463572 T1 AT E463572T1
Authority
AT
Austria
Prior art keywords
factor viii
recombinant factor
specific activity
increased specific
relates
Prior art date
Application number
AT04812686T
Other languages
English (en)
Inventor
Philip Fay
Hironao Wakabayashi
Original Assignee
Univ Rochester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rochester filed Critical Univ Rochester
Application granted granted Critical
Publication of ATE463572T1 publication Critical patent/ATE463572T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT04812686T 2003-12-03 2004-12-02 Rekombinanter faktor viii mit erhöhter spezifischer aktivität ATE463572T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52666403P 2003-12-03 2003-12-03
PCT/US2004/040234 WO2005055930A2 (en) 2003-12-03 2004-12-02 Recombinant factor viii having increased specific activity

Publications (1)

Publication Number Publication Date
ATE463572T1 true ATE463572T1 (de) 2010-04-15

Family

ID=34676640

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04812686T ATE463572T1 (de) 2003-12-03 2004-12-02 Rekombinanter faktor viii mit erhöhter spezifischer aktivität

Country Status (7)

Country Link
US (1) US7855274B2 (de)
EP (1) EP1699469B1 (de)
AT (1) ATE463572T1 (de)
AU (1) AU2004296768B2 (de)
CA (1) CA2547569C (de)
DE (1) DE602004026474D1 (de)
WO (1) WO2005055930A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2371856T3 (en) 2004-11-12 2022-08-08 Bayer Healthcare Llc Site-directed modifikation af FVIII
WO2007011746A2 (en) 2005-07-15 2007-01-25 The University Of Vermont And State Agriculture College Highly sensitive immunoassays and antibodies for detection of blood factor viii
EP2363429A1 (de) 2006-03-10 2011-09-07 Goodrich Corporation Blitzschlagschutz mit geringer Dichte zur Verwendung in Flugzeugen
CA2703948A1 (en) 2007-11-01 2009-05-07 University Of Rochester Recombinant factor viii having increased stability
UA112050C2 (uk) * 2008-08-04 2016-07-25 БАЄР ХЕЛСКЕР ЛЛСі Терапевтична композиція, що містить моноклональне антитіло проти інгібітора шляху тканинного фактора (tfpi)
PT2542257T (pt) 2010-03-01 2017-10-09 Bayer Healthcare Llc Anticorpos monoclonais otimizados contra inibidor da via do fator tecidual (tfpi)
US8637448B2 (en) 2010-09-14 2014-01-28 University Of Rochester Recombinant factor VIII having enhanced stability following mutation at the A1-C2 domain interface
HRP20210031T1 (hr) * 2013-06-24 2021-05-14 Weidong, Xiao Pripravci i metode mutantskog faktora viii
PE20181922A1 (es) 2016-04-15 2018-12-11 Univ Pennsylvania Terapia genica para tratar la hemofilia a
US11471497B1 (en) 2019-03-13 2022-10-18 David Gordon Bermudes Copper chelation therapeutics
CN111651033B (zh) * 2019-06-26 2024-03-05 广州虎牙科技有限公司 一种人脸的驱动显示方法、装置、电子设备和存储介质
WO2026030205A2 (en) * 2024-07-28 2026-02-05 The Regents Of The University Of Colorado, A Body Corporate Composition and method for treating hemophilia using novel factor viii molecule

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5422260A (en) * 1986-05-29 1995-06-06 Genetics Institute, Inc. -Legal Affairs Human factor VIII:c muteins
US5859204A (en) * 1992-04-07 1999-01-12 Emory University Modified factor VIII
US6376463B1 (en) * 1992-04-07 2002-04-23 Emory University Modified factor VIII
US5576291A (en) * 1993-09-13 1996-11-19 Baxter International Inc. Activated factor VIII as a therapeutic agent and method of treating factor VIII deficiency
US5880327A (en) * 1994-09-21 1999-03-09 American National Red Cross Transgenic mammals expressing human coagulation factor VIII
US20040092442A1 (en) * 1996-04-24 2004-05-13 University Of Michigan Inactivation resistant factor VIII
US6458563B1 (en) * 1996-06-26 2002-10-01 Emory University Modified factor VIII
US6593291B1 (en) * 1997-02-06 2003-07-15 Entremed, Inc. Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease
US5994310A (en) * 1998-09-03 1999-11-30 Bayer Corporation Peptide ligands for affinity purification of human Factor VIII
US6759216B1 (en) * 1998-11-06 2004-07-06 Emory University Glycosylated, low antigenicity low immunogenicity factor VIII
EP1038959A1 (de) * 1999-03-17 2000-09-27 Aventis Behring Gesellschaft mit beschränkter Haftung Faktor VIII ohne B-Domän, der ein oder mehrere Insertionsstücke von verkürztem Intron I des Faktors IX enthält
EP1194161B1 (de) * 1999-07-13 2005-11-23 Biovitrum Ab Zusammensetzungen mit stabilem faktor viii
US7771929B2 (en) * 2000-04-28 2010-08-10 Monogram Biosciences, Inc. Tag library compounds, compositions, kits and methods of use
PL206105B1 (pl) * 2000-09-19 2010-07-30 Emory Universityemory University Zmodyfikowany ludzki czynnik VIII oraz sposób modyfikacji ludzkiego czynnika VIII ze zmniejszeniem reaktywności na przeciwciało hamujące i zachowaniem aktywności prokoagulacyjnej
EP1233064A1 (de) * 2001-02-09 2002-08-21 Aventis Behring Gesellschaft mit beschränkter Haftung Modifizierte Faktor VIII cDNA und deren Verwendung bei der Produktion von Faktor VIII
EP1421539B1 (de) * 2001-06-14 2009-10-28 The Scripps Research Institute Stabilisierte faktor viii mit gentechnisch konstruierten disulfidbindungen
EP1424344A1 (de) 2002-11-29 2004-06-02 Aventis Behring Gesellschaft mit beschränkter Haftung Modifizierte cDNA des Factors VIII und Derivate davon
US7041635B2 (en) * 2003-01-28 2006-05-09 In2Gen Co., Ltd. Factor VIII polypeptide
US7211559B2 (en) * 2003-10-31 2007-05-01 University Of Maryland, Baltimore Factor VIII compositions and methods

Also Published As

Publication number Publication date
US7855274B2 (en) 2010-12-21
AU2004296768A1 (en) 2005-06-23
EP1699469B1 (de) 2010-04-07
EP1699469A4 (de) 2007-01-24
WO2005055930A3 (en) 2005-08-18
WO2005055930A2 (en) 2005-06-23
CA2547569A1 (en) 2005-06-23
EP1699469A2 (de) 2006-09-13
US20070265199A1 (en) 2007-11-15
CA2547569C (en) 2013-04-16
AU2004296768B2 (en) 2010-06-24
DE602004026474D1 (de) 2010-05-20

Similar Documents

Publication Publication Date Title
EP2302042A3 (de) Polypeptide mit Lipase-Aktivität und diese kodierende Polynukleotide
NO20042570L (no) Antimikrobielle polypeptider fra Pseudoplectania nigrella
DK1266011T3 (da) Svampetranskriptionsaktivator, der er anvendelig i fremgangsmåder til fremstilling af polypeptider
WO2003000941A3 (en) Polypeptides having cellobiohydrolase i activity and polynucleotides encoding same
EP2857515A3 (de) Polypeptide mit verstärkter amylolytischer Aktivität und Polynukleotide zur Codierung davon
EP2287178A3 (de) Bacillus licheniformis YvmC-Deaktivierung
DK1578964T3 (da) Polypeptider med cellobiohydrolase II-aktivitet og polynukleotider, der koder for samme
BR9814404A (pt) " clonagem de expressão em fungos filamentosos "
EA201070764A1 (ru) Полипептиды, обладающие активностью, усиливающей лизис целлюлозы, и кодирующие их полинуклеотиды
ATE352626T1 (de) Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren
ATE530643T1 (de) Säureaktive fungale protease
ATE471370T1 (de) Varianten von beta-glukosidasen
ATE533839T1 (de) Phytasenvarianten
DE602004026474D1 (de) Rekombinanter faktor viii mit erhöhter spezifischer aktivität
DE602004021836D1 (de) Meg1-endospermspezifische promotoren und gene
DK1117798T3 (da) Fungal transskriptionel aktivator egnet ved fremgangsmåder til produktion af polypeptider
EA200401531A1 (ru) Новые фосфолипазы и их применение
DK1157100T3 (da) Oxaloacetathydrolase-defekte svampeværtsceller
DK0981631T3 (da) Polypeptider, som har aminopeptidase-aktivitet, og nukleinsyrer, som koder for samme
ATE542913T1 (de) Promotorvarianten zur expression von genen in einer pilzzelle
DK1390543T3 (da) Nye polynukleotider og polypeptider af IFNalfa-17-genet
EA200700233A1 (ru) Новая последовательность для повышения экспрессии нуклеиновой кислоты
MX2008002485A (es) Polipeptidos que tienen actividad antimicrobiana y polinucleotidos que los codifican.
WO2006005032A3 (en) Polypeptides having alpha-glucosidase activity and polynucleotides encoding same
ATE445009T1 (de) Signalpeptid zur herstellung eines polypeptids

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties